Evidence map›Paper›PMID 21769619›Full record

ArticleVirchows Archiv : an international journal of pathology2011

Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.

Dionysios J Papachristou, Angeliki Korpetinou, Efstathia Giannopoulou, Anna G Antonacopoulou, Helen Papadaki, Petros Grivas, Chrisoula D Scopa, Haralabos P Kalofonos

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. METTL3-mediated mAmerican journal of cancer research · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.International journal of molecular sciences · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dionysios J PapachristouDepartment of Clinical Oncology, University of Patras, School of Medicine, Patras, Greece.
Angeliki Korpetinou
Efstathia Giannopoulou
Anna G Antonacopoulou
Helen Papadaki
Petros Grivas
Chrisoula D Scopa
Haralabos P Kalofonos
University of Patras · GRUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of colorectal carcinoma (CRC) is a complex process that involves the recruitment of both genetic and epigenetic mechanisms. Recent studies underline the cardinal role of small, noncoding RNA molecules, called microRNAs (miRs), in the pathobiology of numerous physiological and pathological processes, including oncogenesis. MiR biogenesis and maturation is mainly regulated by the nuclear ribonuclease Drosha and the cytoplasmic ribonucleases Dicer and Ago2. In the present study, we investigated the expression and distribution of these molecules in three colon cancer cell lines and in human CRC samples. Drosha, Dicer, and Ago2 mRNA and protein expression was assessed with real-time PCR, western blotting, and immunofluorescence. Our experiments showed that Drosha, Dicer, and Ago2 were expressed in all the cell lines and in the majority of the CRC samples examined. The mRNA levels of Dicer were significantly augmented in stage III compared to stage II tumors. Our results suggest that Drosha, Dicer, and Ago2 are possibly implicated in CRC pathobiology and that Dicer might have a role in the progression of these tumors to advanced stages.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overArgonaute ProteinsBiomarkers, TumorColorectal NeoplasmsDEAD-box RNA HelicasesDisease ProgressionEukaryotic Initiation Factor-2FemaleFluorescent Antibody TechniqueHumansImmunoblottingKaplan-Meier EstimateMaleAGO2 protein, humanArgonaute ProteinsBiomarkers, TumorDEAD-box RNA HelicasesDICER1 protein, humanDROSHA protein, humanEukaryotic Initiation Factor-2Ribonuclease III

Identifiers

PMID21769619
OpenAlexW2113321643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.